Renal Parenchymal Disease

  • Ekkehard RingEmail author
  • Birgit Acham-Roschitz
Part of the Medical Radiology book series (MEDRAD)


Renal parenchymal disease (RPD) is classified into glomerular, tubular, interstitial, and vascular disease. These various diseases may be congenital (hereditary) or acquired. They exclusively may affect the kidneys or are systemic disorders with a wide range of renal contribution. This chapter focuses on the “classic entities” of RPD like glomerulonephritis (GN) or nephrotic syndrome (NS) showing clinical presentation, pathogenesis, renal histology if renal biopsy is indicated, treatment, and prognosis of the various diseases. References are restricted to important new publications where the interested reader can also find suggestions for further reading. The implications for imaging including ultrasound-guided renal biopsy are described in chapter “Imaging in Renal Parenchymal Disease”.


  1. Akchurin O, Reidy KJ (2015) Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology. Pediatr Nephrol 30:221–233CrossRefPubMedGoogle Scholar
  2. Alchi B, Jayne D (2010) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25:1409–1418CrossRefPubMedGoogle Scholar
  3. Alchi B, Griffiths M, Jayne D (2010) What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 25:3147–3154CrossRefPubMedGoogle Scholar
  4. Ayalon R, Beck LH Jr (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31–39CrossRefPubMedGoogle Scholar
  5. Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8–11CrossRefPubMedGoogle Scholar
  6. Barbour TD, Pickering MC, Cook HT (2013) Dense deposit disease and C3 glomerulopathy. Semin Nephrol 33:493–507CrossRefPubMedPubMedCentralGoogle Scholar
  7. Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–12CrossRefPubMedPubMedCentralGoogle Scholar
  8. Becker AM (2011) Sickle cell nephropathy: challenging the conventional wisdom. Pediatr Nephrol 26:2099–2109CrossRefPubMedGoogle Scholar
  9. Berger J, Hinglais N (1968) Les dépôts intercapillaires d’IgA-IgG. J Urol Neprol 74:694–695Google Scholar
  10. Berman H, Rodriguez-Pinto I, Cervera R et al (2014) Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry”. Autoimmun Rev 13:157–162CrossRefPubMedGoogle Scholar
  11. Besbas N, Karpman D, Landau D et al (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423–431CrossRefPubMedGoogle Scholar
  12. Bomback AS, Smith RJ, Barile GR et al (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748–756CrossRefPubMedPubMedCentralGoogle Scholar
  13. Brogan P, Eleftheriou D, Dillon M (2010) Small vessel vasculitis. Pediatr Nephrol 25:1025–1035CrossRefPubMedGoogle Scholar
  14. Cakar N, Özcakar ZB, Soy D et al (2008) Renal involvement in childhood vasculitis. Nephron Clin Pract 108:c202CrossRefPubMedGoogle Scholar
  15. Cara-Fuentes G, Wei C, Segarra A et al (2014) CD80 and suPAR in patients with minimal change disease and focal glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol 29:1363–1371Google Scholar
  16. Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545CrossRefPubMedGoogle Scholar
  17. Coppo R, Troyanov S, Camilla R et al (2010) The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 77:921–927CrossRefPubMedGoogle Scholar
  18. Dallas MH, Triplett B, Shook DR et al (2013) Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 19:820–830CrossRefPubMedPubMedCentralGoogle Scholar
  19. Debiec H, Lefeu F, Kemper MJ et al (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101–2110CrossRefPubMedGoogle Scholar
  20. Delmas Y, Vendrely B, Clouzeau B et al (2014) Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565–572CrossRefPubMedGoogle Scholar
  21. Dillon MJ, Eleftheriou D, Brogan PA (2010) Medium-size-vessel vasculitis. Pediatr Nephrol 25:1641–1652CrossRefPubMedGoogle Scholar
  22. Edvardsson VO, Goldfarb DS, Lieske JC et al (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28:1923–1942CrossRefPubMedPubMedCentralGoogle Scholar
  23. Eison TM, Ault BH, Jones DP et al (2011) Post-streptococcal glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol 26:165–180CrossRefPubMedGoogle Scholar
  24. Eleftheriou D, Brogan PA (2009) Vasculitis in children. Best Pract Res Clin Rheumatol 23:309–323CrossRefPubMedGoogle Scholar
  25. Emma F, Nesterova G, Langman C et al (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29:iv87–iv94CrossRefPubMedPubMedCentralGoogle Scholar
  26. Gauthier B, Trachtman H, Frank R et al (1989) Familial thin basement membrane nephropathy in children with asymptomatic microhematuria. Nephron 51:502–508CrossRefPubMedGoogle Scholar
  27. Gbadegesin R, Winn M, Smoyer WE (2013) Genetic testing in nephrotic syndrome: challenges and opportunities. Nat Rev Nephrol 9:179–184CrossRefPubMedPubMedCentralGoogle Scholar
  28. Gellermann J, Weber L, Pape L et al (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689–1697CrossRefPubMedPubMedCentralGoogle Scholar
  29. Gutierrez E, Zamora I, Ballarin JA et al (2012) Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23:1753–1760CrossRefPubMedPubMedCentralGoogle Scholar
  30. Hinkes BG, Mucha B, Vlangos CN et al (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–e919CrossRefGoogle Scholar
  31. Hochberg MC (1997) Updating the American College of Rheumatology revisited criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMedGoogle Scholar
  32. Houssiau FA, Vasconcelos D, D’Cruz D et al (2012) The 10-year follow-up data of the Euro-Lupus Nepritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 69:61–64CrossRefGoogle Scholar
  33. Huang E, Parke C, Mehrnia A et al (2013) Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrol Dial Transplant 28:1039–1046CrossRefPubMedGoogle Scholar
  34. Ishikura K, Hamasaki Y, Sakai T et al (2012) Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 27:375–384CrossRefPubMedGoogle Scholar
  35. Jahnukainen T, Ala-Houala M, Karikoski R et al (2011) Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol 26:291–299CrossRefPubMedGoogle Scholar
  36. Jais JP, Knebelmann B, Giatras I et al (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol 14:2603–2610CrossRefPubMedGoogle Scholar
  37. Jodele S, Fukuda T, Vinks A et al (2014) Eculizumab therapy in children with severe hematopoietic stem cell transplantation-assiciated thrombotic microangiopathy. Biol Blood Marrow Transplant 20:518–525CrossRefPubMedGoogle Scholar
  38. Joss N, Morris S, Young B et al (2007) Granulomatous interstitial nephritis. Clin J Am Soc Nephrol 2:222–230CrossRefPubMedGoogle Scholar
  39. Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10:651–657CrossRefPubMedGoogle Scholar
  40. Kestilä M, Lenkkeri U, Männikkö M et al (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582CrossRefPubMedGoogle Scholar
  41. Koehler H, Wandel E, Brunck N (1991) Acanthocyturia – A characteristic marker for glomerular bleeding. Kidney Int 40:115–120CrossRefGoogle Scholar
  42. Korkmaz C (2012) Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine. Clin Exp Rheumatol 30(Suppl 72):S104–S107PubMedGoogle Scholar
  43. Krug P, Boyer O, Balzamo E et al (2012) Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol 27:1547–1550CrossRefPubMedGoogle Scholar
  44. Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430CrossRefPubMedGoogle Scholar
  45. Loirat C, Frémeaux-Bacci V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60CrossRefPubMedPubMedCentralGoogle Scholar
  46. Lombel RM, Gipson DS, Hodson EM (2013a) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415–426CrossRefPubMedGoogle Scholar
  47. Lombel RM, Hodson EM, Gipson DS (2013b) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:409–414CrossRefPubMedGoogle Scholar
  48. Lutalo PM, D’Cruz DP (2014) Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun 48–49:94–98CrossRefPubMedGoogle Scholar
  49. Mache CJ, Schwingshandl J, Riccabona M et al (1993) Ultrasound and MRI findings in a case of childhood amyloid goiter. Pediatr Radiol 23:565–566CrossRefPubMedGoogle Scholar
  50. Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V et al (2009) Complement inhibitor Eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312.1316CrossRefPubMedCentralGoogle Scholar
  51. Malina M, Gulati A, Bagga A et al (2013) Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131:e331–e335CrossRefPubMedGoogle Scholar
  52. McKie KT, Hanevold CD, Hernandez C et al (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140–144CrossRefPubMedGoogle Scholar
  53. Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25:1419–1428CrossRefPubMedGoogle Scholar
  54. Murakami M, Yamamoto H, Ueda Y et al (1991) Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol 5:50–53CrossRefPubMedGoogle Scholar
  55. Nesterova G, Gahl WA (2013) Cystinosis: the evolution of a treatable disease. Pediatr Nephrol 28:51–59CrossRefPubMedGoogle Scholar
  56. Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050CrossRefPubMedGoogle Scholar
  57. Ozen S, Pistorio A, Iusan MS et al (2009) The EULAR/PRINTO/PRES criteria for childhood polyarteritis nodosa. Ankara 2008. Ann Rheum Dis 68(Suppl 3):713Google Scholar
  58. Park YH, Choi JY, Chung HS et al (2005) Hematuria and proteinuria in a mass school screening test. Pediatr Nephrol 20:1126–1130CrossRefPubMedGoogle Scholar
  59. Pohl M (2015) Henoch-Schönlein purpura nephritis. Pediatr Nephrol 30:245–252CrossRefPubMedGoogle Scholar
  60. Pozzi C, Andrulli S, Del Veccio L et al (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163CrossRefPubMedGoogle Scholar
  61. Punaro MG (2013) The treatment of systemic lupus proliferative nephritis. Pediatr Nephrol 28:2069–2078CrossRefPubMedGoogle Scholar
  62. Radhakrishnan S, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient. Kidney Int 82:840–856CrossRefPubMedGoogle Scholar
  63. Radhakrishnan S, Lunn A, Kirschfink M et al (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165–1166CrossRefPubMedGoogle Scholar
  64. Rana K, Wang YY, Buzza M et al (2005) The genetics of thin basement membrane nephropathy. Semin Nephrol 25:163–170CrossRefPubMedGoogle Scholar
  65. Rosales A, Hofer J, Zimmerhackl LB et al (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Inf Dis 54:1413–1421CrossRefGoogle Scholar
  66. Savige J, Gregory M, Gross O et al (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364–375CrossRefPubMedGoogle Scholar
  67. Sethi S, Fervenza FC (2011) Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31:341–348CrossRefPubMedGoogle Scholar
  68. Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis – a new look at an old entity. N Engl J Med 366:1119–1131CrossRefPubMedGoogle Scholar
  69. Seyberth HW, Schlingmann KP (2011) Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 26:1789–1802CrossRefPubMedPubMedCentralGoogle Scholar
  70. Sharpe CC, Thein SL (2011) Sickle cell nephropathy – a practical approach. Br J Haematol 155:287–297CrossRefPubMedGoogle Scholar
  71. Shenoy M, Plant ND, Lewis MA et al (2010) Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 25:899–903CrossRefPubMedGoogle Scholar
  72. Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232CrossRefPubMedPubMedCentralGoogle Scholar
  73. Szugye HS, Zeft AS, Spalding SJ (2014) Takayasu arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatric Rheumatology 12:21CrossRefPubMedGoogle Scholar
  74. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMedGoogle Scholar
  75. Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086PubMedGoogle Scholar
  76. Town M, Jean G, Cherqui S et al (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet 18:319–324CrossRefPubMedGoogle Scholar
  77. Tullus M (2012) New developments in the treatment of systemic lupus erythematosus. Pediatr Nephrol 27:727–732CrossRefPubMedGoogle Scholar
  78. Van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26:881–892CrossRefPubMedGoogle Scholar
  79. Vehaskari VM, Rapola J (1982) Isolated Proteinuria: analysis of a school-age population. J Pediatr 101:661–668CrossRefPubMedGoogle Scholar
  80. Vehaskari VM, Rapola J, Koskimies O et al (1979) Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr 95:676–684CrossRefPubMedGoogle Scholar
  81. Vester U, Mache CJ (2014) Pharmacologic treatment of atypical hemolytic-uremic syndrome. Exp Opin Orphan Drugs 2:123–135CrossRefGoogle Scholar
  82. Watanabe T (2013) Kidney and urinary tract involvement in Kawasaki disease. Int J Pediatr Article ID 831834Google Scholar
  83. Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRefGoogle Scholar
  84. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414CrossRefGoogle Scholar
  85. Zand L, Specks U, Sethi S et al (2014) Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Adv Chronic Kidney Dis 21:182–193CrossRefPubMedGoogle Scholar
  86. Zuber J, Fakhouri F, Roumenina LT et al (2012) Use of eculizumab for atypical hemolytic uremic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643–657CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatrics, Division of General PediatricsUniversity Hospital GrazGrazAustria

Personalised recommendations